(Total Views: 581)
Posted On: 05/16/2024 10:30:32 PM
Post# of 148878
I guess I’ll just say it. No I believe Merck is our partner. The CRC trial combined added HIV info kinda gave it away.
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.
Not sure why they haven’t just said it yet.
https://www.biopharmadive.com/news/merck-deal...is/706309/
“The company is also developing combination formulations that pair Keytruda with other immunotherapies aimed at different cellular targets.“
As I had to point out once already today. Leronlimab is an immunotherapy!
Merck I’ll take 115 billon yesterday let’s get this show on the road.
Oh wait you said 15 billon. I guess we shall see.
(7)
(0)Scroll down for more posts ▼
